A Versatile Complement Therapy Across Ocular, Hematologic, Renal, Dermatological, and Inflammatory Disorders. Key Highlights Commercial ...

Biogen’s acquisition of Apellis highlights interest in complement-based ophthalmology and multi-indication platforms. NM5072 represents a broad multi-indication opportunity, supported by preclinical ...

UAB researchers and physician-scientists helped drive a revolution in IgA nephropathy treatment, contributing to clinical ...

Annexon, Inc. ( ANNX) Q2 2026 Earnings Call August 12, 2026 8:00 AM EDT ...

Ductal-origin approach targets two underserved segments, women with dense breasts and those at elevated risk, where ...

Omeros Corporation (Nasdaq: OMER) today announced recent highlights and developments as well as financial results for the second quarter ended June 30, 2026, which include: ...

Researchers at McMaster University have discovered that a naturally occurring hormone best known for suppressing appetite and promoting weight loss ...

Researchers at McMaster University have discovered that a naturally occurring hormone best known for suppressing appetite and ...

RIYADH — Saudi Arabia emerged as one among the world's top 10 countries for private AI investment, according to the latest World Bank report. The World Bank Group's World Development Report 2026, ...

Wandercraft has secured US Food and Drug Administration (FDA) clearance for its self-balancing standing exoskeleton, supporting upright mobility for wheelchair users with spinal cord injuries.

Extron and AV Structural built a centralized, standards-based AV infrastructure using DTP CrossPoint matrix switchers, TouchLink Pro touchpanels, and a 70V audio distribution system across clinical ...

The Hong Kong Trade Development Council (HKTDC) today hosted its flagship overseas promotion, Think Business, Think Hong Kong ...